Browsing by Author School of Public Health: NH&MRC Clinical Trials Centre

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 483 to 502 of 882 < previous   next >
Issue DateTitleAuthor(s)Citation
2013The metabolic syndrome and CVD outcomes for a central Australian cohortJenkins, Alicia; Best, J; Brown, Alex; Daniell, Mark; Luke, Joanne; McDermott, Robyn; O'Dea, Kerin; Rowley, Kevin; Wang, Zaimin; Wang, Zhiqiang; School of Public Health: NH&MRC Clinical Trials CentreThe metabolic syndrome and CVD outcomes for a central Australian cohort, Diabetes Research and Clinical Practice, vol.100, 3, 2013,pp e70-e73
2014Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosisHoussami, Nehmat; Lee, Chee Khoon; Lord, Sarah (Sally); Tjokrowidjaja, Angelina; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreMetastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis, Internal Medicine Journal, vol.44, 8, 2014,pp 764-770
2009Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survivalGebski, Val; Morgan, Gary; Oddone, Nicolas; Palme, Carsten; Perera, Lakmalie; Shannon, Jenny; Veness, Michael; Wong, Eva; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Surgery; Western Clinical School: Surgery; Western Clinical School: Medicine (Westmead); Nepean Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival, Cancer, vol.115, 9,pp 1883-1891
2003Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcomeCakir, Burcu; Veness, Michael; Dona, Eddy; Morgan, Gary J.; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome, ANZ Journal of Surgery, vol.73,(9),2003,pp 692-696
2009Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practiceByth Wilson, Karen; Manolios, Nicholas; Spencer, David; Varatharajan, Nanandan; Anandacoomarasamy, A.; Howe, G; Lim, I; Russo, R; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineMethotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice, Internal Medicine Journal, vol.39, 4,pp 228-236
2014Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Stockler, Martin; Castillo, Lesley; Chatfield, Mark; Clark, Susan J.; Devaney, James; Mallesara, G; Molloy, Peter; Paul, Cheryl; Qu, W; Wykes, R J; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; School of Public Health: NH&MRC Clinical Trials CentreMethylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer, British Journal of Cancer, vol.111, 9, 2014,pp 1802-1809
2014Mid-Gestational Enlargement of Fetal Thalami in Women Exposed to Methadone during PregnancyBenzie, Ronald; Liu, Anthony; Mann, Kristy; Nanan, Ralph; Peek, Michael; Quinton, Ann; Schulson, Meredith; Bjorkman, Tracey; Nepean Clinical School: Obstetrics & Gynaecology; Nepean Clinical School: Paediatrics & Child Health; School of Public Health: NH&MRC Clinical Trials Centre; Nepean Clinical School: Paediatrics & Child Health; Nepean Clinical School: Obstetrics & Gynaecology; Western Clinical School: Obstetrics & Gynaecology; Nepean Clinical School: MedicineMid-Gestational Enlargement of Fetal Thalami in Women Exposed to Methadone during Pregnancy, Frontiers in Surgery, vol.1, N/A, 2014,pp 1-5
2014Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID studyMann, Kristy; Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Funke-Kaiser, Anne; Hunt, David; Sydow, Karsten; Tonkin, Andrew M; West, Malcolm; White, Harvey; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreMidregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study, International Journal of Cardiology, vol.172, 2, 2014,pp 411-418
2010Minimal criteria for the diagnosis of avulsion of the puborectalis muscle by tomographic ultrasoundBernardo, Maria; Dietz, Hans (Peter); Kirby, Adrienne; Shek, Ka Lai; Obstetrics & Gynaecology; Nepean Clinical School: Obstetrics & Gynaecology; School of Public Health: NH&MRC Clinical Trials Centre; Nepean Clinical School: Obstetrics & GynaecologyMinimal criteria for the diagnosis of avulsion of the puborectalis muscle by tomographic ultrasound, International Urogynecology Journal: and pelvic floor dysfunction, vol.N/A, N/A,pp N/A-N/A
2006Missing data methods for the assessment of surrogate outcomes and treatment mechanisms in clinical trial substudies.Galbraith, Sally; Simes, Robert John; Marschner, Ian C.; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreMissing data methods for the assessment of surrogate outcomes and treatment mechanisms in clinical trial substudies., Statistics in Medicine, vol.25,(3),2006,pp 415-431
2006The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?Burgess, David; Burgess, Margaret; Leask, Julie-Anne; School of Public Health: NH&MRC Clinical Trials Centre; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child HealthThe MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?, Vaccine, vol.24,(18),2006,pp 3921-8
2011Modelling the cost of ill health in Health&WealthMOD (Version II): lost labour force participation, income and taxation, and the impact of disease preventionCallander, Emily; Fletcher, Susan; Passey, Megan; Schofield, Deborah; Shrestha, Rupendra; Kelly, Simon John; Percival, Richard; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Rural Health: Lismore; School of Public Health: Rural Health: Lismore; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreModelling the cost of ill health in Health&WealthMOD (Version II): lost labour force participation, income and taxation, and the impact of disease prevention, International Journal of Microsimulation, vol.4, 3, 2011,pp 32-36
2010Modelling the likelihood of levator avulsion in a urogynaecological populationDietz, Hans (Peter); Kirby, Adrienne; Nepean Clinical School: Obstetrics & Gynaecology; School of Public Health: NH&MRC Clinical Trials CentreModelling the likelihood of levator avulsion in a urogynaecological population, Australian and New Zealand Journal of Obstetrics and Gynaecology, vol.50, 3,pp 268-272
2006Moderately premature infants at Kaiser Permanente Medical Care Program in California are discharged home earlier than their peers in Massachusetts and the United Kingdom.Tarnow-Mordi, William; Escobar, G J; McCormick, M C; Parry, Gareth; Profit, J.; Richardson, D K; Tucker, Janet; Zupancic, J A F; School of Public Health: NH&MRC Clinical Trials CentreModerately premature infants at Kaiser Permanente Medical Care Program in California are discharged home earlier than their peers in Massachusetts and the United Kingdom., Archives of disease in childhood. Fetal and neonatal edition, vol.91,(4),2006,pp 245-250
2009Molecular biomarkers to individualise treatment: assessing the evidenceCoates, Alan; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreMolecular biomarkers to individualise treatment: assessing the evidence, Medical Journal of Australia, vol.190, 11,pp 631-636
2008Molecular Grading of Ductal Carcinoma In situ of the BreastBalleine, Rosemary; Byth, Karen; Clarke, Christine; Webster, Lucy; Cornfield, Dennis B; Davis, Sean; Meltzer, Paul S; Palazzo, Juan P.; Salisbury, E.; Schwartz, Gordon F.; Walker, Robert L; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteMolecular Grading of Ductal Carcinoma In situ of the Breast, Clinical Cancer Research, vol.14,(24),2008,pp 8244-8252
2008Molecular markers and the pathogenesis of adrenocortical cancerMcDonald, Kerrie; Robinson, Bruce; Sidhu, Stan; Soon, Patsy; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteMolecular markers and the pathogenesis of adrenocortical cancer, The Oncologist, vol.13, 5, 2008,pp 548-561
2011Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial dataBell, Katy (Catherine); Hayen, Andrew; Irwig, Leslie; Kirby, Adrienne; Glasziou, Paul P; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreMonitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data, BMJ: British Medical Journal, vol.342, d12, 2011,pp 1-7
2008Monitoring cholesterol-modifying interventionsHeritier, Stephane; Irwig, Leslie; Glasziou, Paul; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public HealthMonitoring cholesterol-modifying interventions in Evidence-Based Medical Monitoring: From principles to practice, Blackwell Publishing Ltd, 2008, pp. 245-253
2010Mortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's AgeSimes, Robert John; Boersma, Eric; de Boer, Sanneke P. M.; Granger, Christopher B.; Westerhout, Cynthia M.; Zijlstra, Felix; School of Public Health: NH&MRC Clinical Trials CentreMortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's Age, J A C C: Cardiovascular Interventions, vol.3, 3, 2010,pp 324-331